Immunogenicity of mAbs in non-human primates during nonclinical safety assessment

Immunogenicity of mAbs in non-human primates during nonclinical safety assessment

Item
http://www.wikidata.org/entity/Q30390955
Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic ProteinsSustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus InfectionPre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesFormation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use.Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins.Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in Mice.Immunogenicity of therapeutic protein products: current considerations for anti-drug antibody assay in Japan.A Preclinical Population Pharmacokinetic Model for Anti-CD20/CD3 T-Cell-Dependent Bispecific Antibodies.Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in Patients With Metastatic Solid Tumors.Making individualized drugs a reality.
P2860

Immunogenicity of mAbs in non-human primates during nonclinical safety assessment

Item
http://www.wikidata.org/entity/Q30390955
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@ast
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@en
type
label
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@ast
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@en
prefLabel
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@ast
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932